Changes in the clinical features, treatments, and outcomes of patients with systemic light chain (AL) amyloidosis in Western China, 2010-2022: A multicenter, retrospective, real-world study.

Chin Med J (Engl) · 2024 · PMC11557015 · PMID 39261984

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the post-2018 period, patients receiving anti-plasma cell therapy in the MDT group also showed improved OS compared to the non-MDT group, although the difference did not reach statistical significance [Supplementary Figure 3, http://links.lww.com/CM9/C143 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.